| Samsung Bioepis CH GmbH - Imraldi 40 mg/0.8 ml, Injektionslösung in einer Fertigspritze |
| 67427 | | 01 | | Imraldi 40 mg/0.8 ml | | Injektionslösung in einer Fertigspritze | | L04AB04 | | Adalimumab | | 03.04.2020 | | |
|
| Composition |
| adalimumabum 40 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, histidini hydrochloridum monohydricum, sorbitolum 20 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.375 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Adalimumab | 40mg / 0.8ml |
| | BAG: Active Agent | Dose |
|---|
| Adalimumab | 40 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Histidin Hydrochloride Monohydrate | | | Histidine | | | Natrii Citras Dihydricus | | | Polysorbatum 20 | | | Sorbitol | 20mg / 0.8ml |
| |
|
|
